Concepedia

Jacob I. Contreras

JI

Statistics

Publications

9

Citations

636

H-Index

9

Active since

2016

Affiliations

University of Nebraska Medical Center(Current)

Nebraska Medical Center

Jacob I. Contreras is an author at University of Nebraska Medical Center specializing in medicine, pharmacology, and molecular pharmacology.

ORCID

Publications per year

2016–2021

9

Publications

9

Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)

Caroline M. Robb, Jacob I. Contreras, Smit Kour et al. · Chemical Communications · 2017 · 209 citations

, , +13

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy

Yogesh A. Sonawane, Margaret Taylor, John V. Napoleon et al. · Journal of Medicinal Chemistry · 2016 · 153 citations · Full text

, , +14

Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure–Activity Relationship Study

Sandeep Rana, Elizabeth C. Blowers, Calvin Tebbe et al. · Journal of Medicinal Chemistry · 2016 · 111 citations · Full text

, , +14

Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

Caroline M. Robb, Smit Kour, Jacob I. Contreras et al. · Oncotarget · 2017 · 53 citations · Full text

, , +17

Discovery and characterization of small molecule Rac1 inhibitors

Jamie L. Arnst, Ashley L. Hein, Margaret Taylor et al. · Oncotarget · 2017 · 29 citations · Full text

, , +8

1–5 of 9